Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Valsartan-Hydrochlorothiazide Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 80mg/12.5mg
  • 1.3.3 160mg/12.5mg
  • 1.3.4 320mg/12.5mg
  • 1.3.5 160mg/25mg
  • 1.3.6 320mg/25mg
• 1.4 Market Segment by Application
  • 1.4.1 Global Valsartan-Hydrochlorothiazide Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Drug store
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Valsartan-Hydrochlorothiazide Market Size
  • 2.1.1 Global Valsartan-Hydrochlorothiazide Revenue 2014-2025
  • 2.1.2 Global Valsartan-Hydrochlorothiazide Sales 2014-2025
• 2.2 Valsartan-Hydrochlorothiazide Growth Rate by Regions
  • 2.2.1 Global Valsartan-Hydrochlorothiazide Sales by Regions 2014-2019
  • 2.2.2 Global Valsartan-Hydrochlorothiazide Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Valsartan-Hydrochlorothiazide Sales by Manufacturers
  • 3.1.1 Valsartan-Hydrochlorothiazide Sales by Manufacturers 2014-2019
  • 3.1.2 Valsartan-Hydrochlorothiazide Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Valsartan-Hydrochlorothiazide Revenue by Manufacturers (2014-2019)
  • 3.2.2 Valsartan-Hydrochlorothiazide Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Valsartan-Hydrochlorothiazide Market Concentration Ratio (CR5 and HHI)
• 3.3 Valsartan-Hydrochlorothiazide Price by Manufacturers
• 3.4 Key Manufacturers Valsartan-Hydrochlorothiazide Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Valsartan-Hydrochlorothiazide Market
• 3.6 Key Manufacturers Valsartan-Hydrochlorothiazide Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 80mg/12.5mg Sales and Revenue (2014-2019)
  • 4.1.2 160mg/12.5mg Sales and Revenue (2014-2019)
  • 4.1.3 320mg/12.5mg Sales and Revenue (2014-2019)
  • 4.1.4 160mg/25mg Sales and Revenue (2014-2019)
  • 4.1.5 320mg/25mg Sales and Revenue (2014-2019)
• 4.2 Global Valsartan-Hydrochlorothiazide Sales Market Share by Type
• 4.3 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type
• 4.4 Valsartan-Hydrochlorothiazide Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Valsartan-Hydrochlorothiazide Sales by Application

6 United States

• 6.1 United States Valsartan-Hydrochlorothiazide Breakdown Data by Company
• 6.2 United States Valsartan-Hydrochlorothiazide Breakdown Data by Type
• 6.3 United States Valsartan-Hydrochlorothiazide Breakdown Data by Application

7 European Union

• 7.1 European Union Valsartan-Hydrochlorothiazide Breakdown Data by Company
• 7.2 European Union Valsartan-Hydrochlorothiazide Breakdown Data by Type
• 7.3 European Union Valsartan-Hydrochlorothiazide Breakdown Data by Application

8 China

• 8.1 China Valsartan-Hydrochlorothiazide Breakdown Data by Company
• 8.2 China Valsartan-Hydrochlorothiazide Breakdown Data by Type
• 8.3 China Valsartan-Hydrochlorothiazide Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Valsartan-Hydrochlorothiazide Breakdown Data by Company
• 9.2 Rest of World Valsartan-Hydrochlorothiazide Breakdown Data by Type
• 9.3 Rest of World Valsartan-Hydrochlorothiazide Breakdown Data by Application
• 9.4 Rest of World Valsartan-Hydrochlorothiazide Breakdown Data by Countries
  • 9.4.1 Rest of World Valsartan-Hydrochlorothiazide Sales by Countries
  • 9.4.2 Rest of World Valsartan-Hydrochlorothiazide Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Novartis
  • 10.1.1 Novartis Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.1.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.1.5 Novartis Recent Development
• 10.2 Teva
  • 10.2.1 Teva Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.2.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.2.5 Teva Recent Development
• 10.3 Lupin
  • 10.3.1 Lupin Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.3.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.3.5 Lupin Recent Development
• 10.4 Aurobindo Pharma
  • 10.4.1 Aurobindo Pharma Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.4.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.4.5 Aurobindo Pharma Recent Development
• 10.5 Torrent Pharmaceuticals
  • 10.5.1 Torrent Pharmaceuticals Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.5.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.5.5 Torrent Pharmaceuticals Recent Development
• 10.6 Par Pharmaceutical
  • 10.6.1 Par Pharmaceutical Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.6.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.6.5 Par Pharmaceutical Recent Development
• 10.7 Huaren Pharmaceutical
  • 10.7.1 Huaren Pharmaceutical Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.7.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.7.5 Huaren Pharmaceutical Recent Development
• 10.8 Mylan
  • 10.8.1 Mylan Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.8.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.8.5 Mylan Recent Development
• 10.9 Alembic Pharmaceuticals
  • 10.9.1 Alembic Pharmaceuticals Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.9.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.9.5 Alembic Pharmaceuticals Recent Development
• 10.10 Zhejiang Huahai Pharmaceutical
  • 10.10.1 Zhejiang Huahai Pharmaceutical Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Valsartan-Hydrochlorothiazide
  • 10.10.4 Valsartan-Hydrochlorothiazide Product Introduction
  • 10.10.5 Zhejiang Huahai Pharmaceutical Recent Development
• 10.11 APOTEX
• 10.12 MACLEODS
• 10.13 Chongqing Conquer Pharmaceutical
• 10.14 Beijing Second Pharmaceutical
• 10.15 Cisen Pharmaceutical

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Valsartan-Hydrochlorothiazide Sales Channels
  • 11.2.2 Valsartan-Hydrochlorothiazide Distributors
• 11.3 Valsartan-Hydrochlorothiazide Customers

12 Market Forecast

• 12.1 Global Valsartan-Hydrochlorothiazide Sales and Revenue Forecast 2019-2025
• 12.2 Global Valsartan-Hydrochlorothiazide Sales Forecast by Type
• 12.3 Global Valsartan-Hydrochlorothiazide Sales Forecast by Application
• 12.4 Valsartan-Hydrochlorothiazide Forecast by Regions
  • 12.4.1 Global Valsartan-Hydrochlorothiazide Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Valsartan-Hydrochlorothiazide Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

This drug is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: valsartan and hydrochlorothiazide. Valsartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a "water pill" (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water.
In 2019, the market size of Valsartan-Hydrochlorothiazide is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Valsartan-Hydrochlorothiazide.

This report studies the global market size of Valsartan-Hydrochlorothiazide, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Valsartan-Hydrochlorothiazide sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novartis
Teva
Lupin
Aurobindo Pharma
Torrent Pharmaceuticals
Par Pharmaceutical
Huaren Pharmaceutical
Mylan
Alembic Pharmaceuticals
Zhejiang Huahai Pharmaceutical
APOTEX
MACLEODS
Chongqing Conquer Pharmaceutical
Beijing Second Pharmaceutical
Cisen Pharmaceutical

Market Segment by Product Type
80mg/12.5mg
160mg/12.5mg
320mg/12.5mg
160mg/25mg
320mg/25mg

Market Segment by Application
Hospital
Drug store

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Valsartan-Hydrochlorothiazide status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Valsartan-Hydrochlorothiazide manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Valsartan-Hydrochlorothiazide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025